The Josh Bersin Company, the world’s most trusted HR advisory firm, today publishes a practical guide for CHRO and L&D leaders on the future of skills...
Shift Bioscience, a biotech company using an AI powered virtual cell to fight age-related diseases, announced the appointments of Jill Reckless, Ph.D, as Translation Advisor...
Leading nephrologists Dr. An De Vriese and Dr. Monnie Wasse join as Company continues clinical advancement Xeltis, a leading developer of transformative implants that enable the natural...
The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors Define Ventures, one of the largest...
SimCare AI, founded by two University of Chicago dropouts, has secured $2 million in seed funding to expand its AI-driven healthcare simulation platform. The company’s...
METiS Pharmaceuticals, a clinical-stage, AI-driven biotechnology company specializing in innovative drug delivery technologies, today announced the appointment of Mark Herbert as Chief Business Officer (CBO), effective January 22,...
Identiv and Novanta to market new RFID-based solutions that fill much needed gap for medical device and pharmaceutical manufacturers. Novanta Inc., a global technology supplier to...
Expanded collaboration agreement with Allogene includes investment for further MRD assay development, clinical sample testing, milestone payments, and international expansion Foresight Diagnostics (“the Company”), a...
AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today announced the appointment of two senior leaders: Clayton Edwards, RPh, MBA,...
RefleXion Medical, a theranostic oncology company, today announced the appointment of Steve Schoch as chief financial officer (CFO) and the promotion of Phil Aulson to...
Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights that will empower researchers and clinicians to improve human health, today announced the...
Dr. Rousseau to lead clinical development as Pheast advances PHST001, a novel anti-CD24 macrophage checkpoint inhibitor, into clinical trials Pheast Therapeutics, a private biotechnology company...
Gravie, one of the nation’s fastest growing health benefits innovators, has named Steve Wolin as the company’s new chief executive. Wolin succeeds Gravie Co-founder and CEO Abir Sen,...
Avid Bioservices, Inc., a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services...
Ingenovis Health today announced the promotion of Jan Ross to Chief Information Officer, effective immediately. Ross joined the company in March 2023 as Senior Vice...